References
1. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992;71:206–15.10.1097/00005792-199207000-00003Search in Google Scholar
2. Cicardi M, Banerjo A, Bracho F, Malbràn A, Rosenkranz B, Riedl M, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 2010;363:532–41.10.1056/NEJMoa0906393Search in Google Scholar
3. Moldovan D, Reshef A, Fabiani J, Kivity S, Toubi E, Shlesinger M, et al. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. Clin Exp Allergy 2012;42:929–35.10.1111/j.1365-2222.2012.03984.xSearch in Google Scholar
4. Cugno M, Nussberger J, Cicardi M, Agostoni A. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 2003;3:311–7.10.1016/S1567-5769(02)00162-5Search in Google Scholar
5. Cillari E, Misiano G, Aricò M, La Rocca E, Lio D, Di Leonardo S, et al. Modification of peripheral blood T-lymphocyte surface receptors and Langerhans cell numbers in hereditary angioedema. Am J Clin Pathol 1986;85:305–11.10.1093/ajcp/85.3.305Search in Google Scholar
6. Prada AE, Zahedi K, Davis AE 3rd. Regulation of C1 inhibitor synthesis [review]. Immunobiology 1998;199:377–88.10.1016/S0171-2985(98)80042-9Search in Google Scholar
7. Gluszko P, Undas A, Amenta S, Szczeklik A, Schmaier AH. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor. J Lab Clin Med 1994;123:232–40.Search in Google Scholar
8. West B, Welch K, Galecki A. Linear mixed models: a practical guide using statistical software. London: Chapman & Hall/CRC, 2007:21–9.Search in Google Scholar
9. Coelho dos Santos JS, Menezes CA, Villani FN, Magalhães LM, Scharfstein J, Gollob KJ, et al. Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells. Clin Exp Immunol 2010;162:528–36.10.1111/j.1365-2249.2010.04270.xSearch in Google Scholar PubMed PubMed Central
10. Platten M, Youssef S, Hur EM, Ho PP, Han MH, Lanz TV, et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17 mediated autoimmunity. Proc Natl Acad Sci USA 2009;106:14948–53.10.1073/pnas.0903958106Search in Google Scholar PubMed PubMed Central
©2014 by Walter de Gruyter Berlin/Boston
